Search results for "transcriptional activity"

showing 4 items of 4 documents

Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia

2019

Background: TP73 isoforms gained particular relevance in acute promyelocytic leukemia (APL) since Bernasola et al (JEM. 2004) demonstrated that TAp73 was directly regulated by the PML protein in the nuclear body. The isoforms differ in their transcriptional activity, with those lacking domains in the N-terminal part of the protein exerting a dominant negative effect on TP73 function. In a retrospective analysis of patients with APL treated in ICAPL study, Lucena-Araujo et al (Blood 2015) demonstrated the association between higher ΔNp73/TAp73 ratio values and poor clinical outcome. However,there is a diversity of TP73 isoforms and specially those lacking N-terminal domains (e.g.ΔEx2p73, ΔEx…

Acute promyelocytic leukemiaTranscriptional activitymedicine.medical_specialtySupervisory boardbusiness.industryeducationImmunologyDisease progressionCell BiologyHematologyNewly diagnosedmedicine.diseaseBiochemistryFamily medicinemedicineFunctional studiesProtein abundancebusinessHematology+Oncologyhealth care economics and organizationsBlood
researchProduct

Different Transcriptional Activity and In Vitro TNF-α Production in Psoriasis Patients Carrying the TNF-α 238A Promoter Polymorphism

2000

Genes encoded on chromosome 6 within the major histocompatibility complex region are thought to play an important role in the pathogenesis of psoriasis. A potential candidate gene is tumor necrosis factor alpha. The tumor necrosis factor alpha promoter contains several polymorphisms including two G--A transitions at position -308 and -238, which are the most common in Caucasian populations. The TNF238.2 (-238A) allele has been strongly associated with psoriasis. We have investigated the effect of the -238 and -308 variants on transcription of the tumor necrosis factor alpha gene in luciferase reporter gene assays. In addition, peripheral blood mononuclear cells of 47 patients with psoriasis…

AdultMaleTranscription Geneticmedicine.medical_treatmentT cellDermatologyBiologyBiochemistryPeripheral blood mononuclear cellAntigenPsoriasisTNFαmedicineSuperantigenHumansPsoriasisPromoter Regions GeneticMolecular Biologytranscriptional activityAgedAged 80 and overPBMGPolymorphism GeneticTumor Necrosis Factor-alphaPromoterCell BiologyMiddle Agedmedicine.diseaseMolecular biologypromoter polymorphismCytokinemedicine.anatomical_structureImmunologyLeukocytes MononuclearFemaleTumor necrosis factor alphaJournal of Investigative Dermatology
researchProduct

The consequences of regulation of desat1 expression for pheromone emission and detection in Drosophila melanogaster.

2010

AbstractSensory communication depends on the precise matching between the emission and the perception of sex- and species-specific signals; understanding both the coevolutionary process and the genes involved in both production and detection is a major challenge. desat1 determines both aspects of communication—a mutation in desat1 simultaneously alters both sex pheromone emission and perception in Drosophila melanogaster flies. We investigated whether the alteration of pheromonal perception is a consequence of the altered production of pheromones or if the two phenotypes are independently controlled by the same locus. Using several genetic tools, we were able to separately manipulate the tw…

Fatty Acid DesaturasesMaleTranscription Genetic[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionMESH : Animals Genetically ModifiedMESH : GenotypeMESH: GenotypeAnimals Genetically ModifiedSexual Behavior AnimalMESH : HydrocarbonsMESH: Reverse Transcriptase Polymerase Chain ReactionMESH : Drosophila melanogasterDrosophila ProteinsMESH: AnimalsMESH : FemaleMESH: Sexual Behavior AnimalSex AttractantsGeneticsMESH: Nursing AssessmentMESH : Craniocerebral TraumabiologyMESH : Gene Expression RegulationReverse Transcriptase Polymerase Chain ReactionMESH : Fatty Acid DesaturasesMESH : Reverse Transcriptase Polymerase Chain ReactionMESH: Fatty Acid DesaturasesMESH: Gene Expression RegulationPhenotypeMESH: Intracranial PressureMESH: Sex AttractantsDrosophila melanogasterSex pheromonePheromoneFemaleDrosophila melanogasterMESH : MutationMESH: MutationGenotypeMESH : ComaMESH: Drosophila ProteinsMESH : MaleMESH: Craniocerebral TraumaSensory systemLocus (genetics)InvestigationsMESH: Drosophila melanogasterMESH: Animals Genetically ModifiedMESH: HydrocarbonsMESH: Education Nursing ContinuingGeneticsMESH : Nursing AssessmentAnimalsMESH : Sexual Behavior AnimalGeneMESH: ComaTranscriptional activityMESH : Sex AttractantsMESH: HumansMESH: Transcription GeneticMESH : HumansMESH : Transcription Geneticbiology.organism_classificationMESH : Drosophila ProteinsMESH: MaleHydrocarbonsMESH : Intracranial PressureGene Expression RegulationMutationMESH : AnimalsMESH : Education Nursing ContinuingMESH: Female[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

2006

Item does not contain fulltext BACKGROUND: Loss of TP53 function through gene mutation is a critical event in the development and progression of many tumour types including colorectal cancer (CRC). In vitro studies have found considerable heterogeneity amongst different TP53 mutants in terms of their transactivating abilities. The aim of this work was to evaluate whether TP53 mutations classified as functionally inactive (< or=20% of wildtype transactivation ability) had different prognostic and predictive values in CRC compared with mutations that retained significant activity. MATERIALS AND METHODS: TP53 mutations within a large, international database of CRC (n = 3583) were classified ac…

Oncologyp53MaleNutrition and Diseasebinding domainsLymphovascular invasionColorectal cancerDNA Mutational AnalysisAetiology screening and detection [ONCOL 5]Gene mutationmedicine.disease_causeTransactivationVoeding en ZiekteAntineoplastic Combined Chemotherapy ProtocolsDeterminants in Health and Disease [EBP 1]transcriptional activityMutationHematologyExonsMiddle AgedSurvival RateOncologyAdenocarcinomaFemaleColorectal Neoplasmsmedicine.medical_specialtyAdenocarcinomachemotherapy colorectal cancer mutation prognosis TP53 transactivational abilityMolecular epidemiology [NCEBP 1]Breast cancerTranslational research [ONCOL 3]Interventional oncology [UMCN 1.5]Internal medicinemedicineHumansNeoplasm InvasivenessSurvival rateneoplasmsbreast-cancerVLAGAgedNeoplasm StagingHereditary cancer and cancer-related syndromes [ONCOL 1]business.industryInternational Agenciesmedicine.diseaseImmunologyMutationTumor Suppressor Protein p53businessFollow-Up Studies
researchProduct